Literature DB >> 1447492

Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization.

M Nesović1, J Cirić, S Radojković, M Zarković, M Durović.   

Abstract

We report the results of transcatheter intraarterial perfusion of liver with the emulsion of iodized oil and cytostatics performed as palliative treatment in three patients with hepatic metastases of pancreatic endocrine tumors. Two patients had insulinoma and one patient had glucagonoma. They were also treated by medical therapy from the time the diagnosis was made. Intraarterial perfusion of the liver was achieved by Lipiodol emulsified with streptozotocin and 5-fluorouracil. Regarding these three patients therapeutic responses were different in duration of hormone secretion decrease. Relief of hypoglycemic attacks and a significant decrease of plasma immunoreactive insulin concentration within 12 months without any additional therapy was observed in the patient with insulinoma (case no. 2). This patient had slightly increased immunoreactive glucagon concentration from the time of diagnosis. A decrease of immunoreactive insulin levels in other patient with insulinoma and an increase in plasma glucose to the euglycemic range during two months allowed a reduction of doses of somatostatin analogue and diazoxide. Due to rapid progression of the disease, intraarterial perfusion of liver was repeated three months later with the same results. Remission of symptoms was partial in the case of glucagonoma. Immunoreactive glucagon levels were not changed and there was no significant benefit of the treatment. Intraarterial perfusion of liver with iodized oil and cytostatics could be an effective, safe and repeatable method of palliating symptoms of malignant pancreatic tumors, especially in inoperable but nonterminal cases. It could allow reduction of additional medical therapy, but success of the treatment is not predictable.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1447492     DOI: 10.1007/BF03348803

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  A malignant insulinoma transformed into a glucagonoma syndrome.

Authors:  A Ohneda; M Otsuki; H Fujiya; N Yaginuma; T Kokubo; H Ohtani
Journal:  Diabetes       Date:  1979-11       Impact factor: 9.461

2.  Malignant islet-cell tumors of the pancreas.

Authors:  N W Thompson; F E Eckhauser
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

3.  Current and future applications of angiography in the abdomen.

Authors:  E K Lang
Journal:  Radiol Clin North Am       Date:  1979-04       Impact factor: 2.303

4.  Chemoembolization: transcatheter management of neoplasms.

Authors:  V P Chuang; S Wallace
Journal:  JAMA       Date:  1981-03-20       Impact factor: 56.272

5.  Improvement of metastatic glucagonoma by hepatic artery embolization.

Authors:  R Jian; J A Seyrig; A Roche; R Modigliani; Y Lenormand; M Hautefeuille
Journal:  Gastroenterology       Date:  1984-08       Impact factor: 22.682

Review 6.  Glucagonoma syndrome.

Authors:  S R Bloom; J M Polak
Journal:  Am J Med       Date:  1987-05-29       Impact factor: 4.965

7.  Metastatic insulinoma with long survival and glucagonoma syndrome.

Authors:  C M D'Arcangues; S Awoke; G D Lawrence
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

Review 8.  The clinical use of somatostatin analogues in the treatment of cancer.

Authors:  S W Lamberts; E P Krenning; J G Klijn; J C Reubi
Journal:  Baillieres Clin Endocrinol Metab       Date:  1990-03

9.  Pancreatic polypeptide and calcitonin secretion from a pancreatic tumour-clinical improvement after hepatic artery embolization.

Authors:  A Manche; S M Wood; T E Adrian; R B Welbourn; S R Bloom
Journal:  Postgrad Med J       Date:  1983-05       Impact factor: 2.401

10.  Hepatic artery embolization in the treatment of intractable hypoglycaemia.

Authors:  J L Wells; D A Heath; R J West
Journal:  J R Soc Med       Date:  1990-09       Impact factor: 18.000

View more
  3 in total

Review 1.  Malignant insulinoma: spectrum of unusual clinical features.

Authors:  Boaz Hirshberg; Craig Cochran; Monica C Skarulis; Steven K Libutti; H Richard Alexander; Bradford J Wood; Richard Chang; David E Kleiner; Phillip Gorden
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

Review 2.  Liver embolizations in oncology: a review. Part I. Arterial (chemo)embolizations.

Authors:  Peter Gunvén
Journal:  Med Oncol       Date:  2007-08-03       Impact factor: 3.064

3.  Insulinoma: A rare cause of hypoglycemia in a young female.

Authors:  Fnu Kelash; James Mulinda
Journal:  J Community Hosp Intern Med Perspect       Date:  2014-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.